LATEST
Oncology
Infectious Disease
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES
In, , ,

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

During an industry-sponsored symposium at the recent 24th Asia-Pacific League of Associations for Rheumatology (APLAR) Congress, Dr Ho So of The Chinese University of Hong Kong evaluated up-to-date evidence on the effectiveness and safety of coronavirus disease (COVID-19) vaccines in patients with autoimmune rheumatic diseases (ARDs).

OTHER
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers
irAE-immune-related-adverse-events-immune-mediated-adverse-events-hepatitis-pneumonitis-rash-diabetes

Therapeutic Areas

Newsletter


Therapeutic Areas

Latest
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers
ONCOLOGY
Local Updates on COVID-19 Prevention and Treatment

Local Updates on COVID-19 Prevention and Treatment

Coronavirus Disease 2019 (COVID-19) emerged in late 2019 and later transformed into a pandemic. Since the United States Food and Drug Administration (FDA) granted Emergency Use Authorisation for COVID-19 vaccines.

Infectious Disease
Other
Personalised Angina Treatment at Cellular Level

Personalised Angina Treatment at Cellular Level

At the Advances in Medicine 2022 Virtual Conference on 29th May 2022, Professor Luis Gowdak, a clinical scientist at the Heart Institute in São Paulo, Brazil, presented on individualising medical treatment for patients with chronic coronary syndromes.

irAE-immune-related-adverse-events-immune-mediated-adverse-events-hepatitis-pneumonitis-rash-diabetes